Applying Subtractive Hybridization Technique to Enrich and Amplify Tumor-Specific Transcripts of Esophageal Squamous Cell Carcinoma
- 200 Downloads
Subtractive hybridization (SH) as an efficient and powerful approach can be applied to isolate differentially expressed transcripts as well as detect of involved mRNAs in various cellular processes, particularly diseases and malignancies. This procedure leads to the enrichment of specific low copy transcripts of tumor cells. Having developed a new approach for SH to isolate tumor specific transcripts, we facilitated discovery of uniquely expressed genes in esophageal squamous cell carcinoma (ESCC). Total RNA was extracted from the fresh tumoral and their adjacent normal tissues, and purified using the Switch Mechanism At the 5ʹ end of Reverse Transcript (SMART) method. Following cDNA synthesis of normal mRNAs using magnetic beads, it was hybridized with tumor mRNAs. To enhance efficiency of subtraction, hybridization was repeated three rounds. Finally, amplification of subtracted tumor-specific transcripts was carried out using in vitro transcription. The subtracted tumoral mRNAs was analyzed quantitatively using real-time PCR for both tumor-specific and housekeeping genes. The subtracted mRNA was confirmed as tumor-specific mRNA pool using RT-PCR and quantitative real-time PCR assessment. The elevated level of tumor-specific transcripts such as MAGE-A4 and CD44 as well as declined copy number of housekeeping genes such as GAPDH, β actin and β2-microglobulin, were confirmed in subtracted tumoral mRNA. The presence of tumor genes was confirmed after the SH procedure. The designed SH method in combination with SMART technique can isolate and amplify high quality tumor-specific transcripts even from small amount of tumor tissues. Removal of common transcripts from the extracted tumoral mRNAs using SH, leads to the enrichment of tumor-specific transcripts. The isolated transcripts are of interest because of their probable roles in ESCC progression and development. In addition, these tumor-specific mRNAs can be applied for future vaccine cancer studies.
KeywordsSubtractive hybridization ESCC. Enrichment Tumor-specific transcripts SMART
The authors gratefully acknowledge the colleagues at Division of Human Genetics and Immunology Department in Mashhad University of Medical Sciences for their technical assistance.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
This study was supported by a grant from Vice chancellor of Mashhad University of Medical Sciences (#911302).
Informed consent was obtained from all individual participants included in the study.
- 1.Moghbeli M, Moghbeli F, Forghanifard MM, Garayali A, Abbaszadegan MR (2013) Cancer stem cell markers in esophageal cancer. Am J Cancer Sci 2(1):37–50Google Scholar
- 4.Gholamin M, Moaven O, Farshchian M, Mahmoudi M, Sankian M, Memar B, et al. (2010) Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design. BMC Cancer 10(1):261CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Kurtz DM, Gambhir SS (2014) Tracking cellular and immune therapies in cancer. Emerging Applications of Molecular Imaging to Oncology, 124:257-296Google Scholar
- 8.Forghanifard MM, Gholamin M, Farshchian M, Moaven O, Memar B, Forghani MN, et al. (2011) Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy. Cancer Biol Ther 12(3):191–197CrossRefPubMedGoogle Scholar
- 9.Bringmann A, Held SAE, Heine A, Brossart P (2010) RNA vaccines in cancer treatment. BioMed Res Int 2010Google Scholar
- 12.Forghanifard MM, Amani J, Gheybi E, Abbaszadegan MR (2012) In silico analysis of chimeric polytope of cancer/testis antigens for dendritic cell-based immune-gene therapy applications. Gene Ther Mol Biol 14:87–96Google Scholar
- 16.Gholamin M, Moaven O, Farshchian M, Rajabi-Mashhadi MT, Mahmoudi M, Sankian M, et al. (2010) Highly efficient transfection of dendritic cells derived from esophageal squamous cell carcinoma patient: optimization with green fluorescent protein and validation with tumor RNA as a tool for immuno-genetherapy. Iran J Biotechnol 8(2):121–126Google Scholar
- 21.Lin T-Y, Ying, S-Y (2003) Subtractive hybridization for the identification of differentially expressed genes using uraci-DNA glycosylase and mung-bean nuclease. Generation of cDNA Libraries. Springer, p 239-251Google Scholar
- 22.Wang Z, Jones, MGK (2003) cDNA generation on paramagnetic beads. Generation of cDNA Libraries. Springer, p 25-31Google Scholar
- 25.Alsadat Mahmoudian R, Abbaszadegan MR, Mansouri A, Gholamin M (2015) Amplification of Tumor Transcripts from Limited Quantity of Esophageal Squamous Cell Carcinoma Tissue Samples. Am J Cancer Sci 4(1):54–62Google Scholar
- 41.Blumberg B, Belmonte, JCI. (1999) Subtractive hybridization and construction of cDNA libraries. Molecular Embryology. Springer, p 555–574.Google Scholar
- 46.Smith CL, Bouchard J, Surdi G, Nguyen G, Pimpis K, Tolstoi LG (2000) Comparative genomics: differential display and subtractive hybridization. Encycl Anal Chem 6:4893–4901Google Scholar
- 47.Seth D, Gorrell MD, McGuinness PH, Leo MA, Lieber CS, McCaughan GW, et al. (2003) SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. J Biochem Biophys Methods 55(1):53–66CrossRefPubMedGoogle Scholar
- 48.Hsu F-M, Cheng JC-H, Chang Y-L, Lee J-M, Koong AC, Chuang EY (2015) Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation. Sci Report 5Google Scholar